HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer.

Gastric Cancer · 2015 · PMC4511072 · PMID 25038874

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

When variability in staining intensity was explored by IHC category, patients with IHC 2+ and IHC 3+ scores showed a treatment benefit regardless of variability, with a numerical trend toward greater benefit in patients with >30 % cells stained.

also in 723 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.